The main market opportunities in the eosinophilic esophagitis pipeline include focusing on novel therapeutic approaches, potential development of first-in-class treatments like IRL201104, targeting ...

Among patients with eosinophilic esophagitis (EoE), both those who are responsive to proton pump inhibitors (PPIs) and those who are unresponsive to PPI treatment share similar esophageal protein ...

Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Cendakimab sustained improvements in symptoms and ...

Adults with eosinophilic esophagitis (EoE) showed elevated levels of various food allergen–specific antibodies other than immunoglobulin G4 (IgG4), challenging the focus on IgG4 as a solitary marker ...

Mirna Chehade, MD, MPH, discusses the challenges faced by patients with eosinophilic esophagitis (EoE), including the absence of predictive factors for personalized treatment, the social implications ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

Ready to experience “The End of Evangelion” on the big screen? GKIDS, the producer and distributor of some of the very best animated features from around the world announced that it will bring “The ...

Please provide your email address to receive an email when new articles are posted on . Histologic outcomes were similar regardless of whether budesonide-treated patients underwent dilation. More ...